Výsledky vyhledávání - "PO Schischmanoff"

Routine use of natriuretic peptides: Lessons from a big data analysis

Autor: Sonia MSadek, Tanissia Boukertouta, PO Schischmanoff, Christophe Meune, Francois-Xavier Goudot

Publikováno v: Annals of clinical biochemistry. 58(5)

Background Natriuretic peptides have broad indications during heart failure and the detection of left ventricular dysfunction in high-risk patients. They can also be used for the diagnosis/management of other cardiac diseases. However, very little is

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::75d456470f68d74ef7082ff70f3d29c5
https://pubmed.ncbi.nlm.nih.gov/34006120

Zobrazit plný text záznamu

Inhibine et molécules apparentées. Structures, activités biologiques et méthodes de dosage

Autor: PO Schischmanoff, JM Bidart

Publikováno v: Immuno-analyse & Biologie Spécialisée. 6:9-15

Resume L'inhibine est une hormone glycoproteique d'origine gonadique qui diminue de facon selective la secretion antehypophysaire d'hormone folliculo-stimulante (FSH). L'inhibine peut etre mesuree soit in vivo par des techniques indirectes qui metten

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_________::54ae441bfeb2c97f22a199f60cbf9e3b
https://doi.org/10.1016/s0923-2532(05)80442-9

Zobrazit plný text záznamu

Natural history of hereditary spherocytosis during the first year of life

Autor: Francois Delhommeau, Cynober T, Po, Schischmanoff, Rohrlich P, Delaunay J, Mohandas N, Tchernia G

Publikováno v: Europe PubMed Central

Although hereditary spherocytosis (HS) is a common disorder of the red cell membrane, its clinical and biologic expression at birth and in early infancy has received little attention. In order to obtain insights into the natural history of HS during

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=pmid_dedup__::31a08b90278bf2eb258f40c66a2ead46
https://pubmed.ncbi.nlm.nih.gov/10627440

Zobrazit plný text záznamu

Prognostic impact of microsatellite instability in colorectal cancer patients treated with adjuvant FOLFOX

Autor: Jf, Morere, Po, Schischmanoff, Lagorce C, Cucherousset J, Sastre X, Boisseau A, Nicolas P, Uzzan B, Mariani P, Lecaille C, Des Guetz G, Mohammed Bennamoun

Publikováno v: Scopus-Elsevier
Publons

Colorectal cancer (CRC) patients whose tumours have microsatellite instability (MSI) do not benefit from adjuvant 5-fluorouracil. However, the predictive value of MSI is not known for FOLFOX, now recommended in adjuvant setting.MSI phenotype was asse

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=pmid_dedup__::71a09d92d3c4c5d151988d2f0f816a46
http://www.scopus.com/inward/record.url?eid=2-s2.0-78650249084&partnerID=MN8TOARS

Zobrazit plný text záznamu

Akademický článek

Routine use of natriuretic peptides: Lessons from a big data analysis.

Autor: Goudot FX; Cardiology Department, Avicenne University Hospital, APHP, Université Sorbonne Paris Nord, Bobigny, France., Msadek S; Cardiology Department, Avicenne University Hospital, APHP, Université Sorbonne Paris Nord, Bobigny, France., Boukertouta T; Cardiology Department, Avicenne University Hospital, APHP, Université Sorbonne Paris Nord, Bobigny, France., Schischmanoff PO; Biochemistry Department, Avicenne University Hospital, APHP, Université Sorbonne Paris Nord, Bobigny, France., Meune C; Cardiology Department, Avicenne University Hospital, APHP, Université Sorbonne Paris Nord, Bobigny, France.

Publikováno v: Annals of clinical biochemistry [Ann Clin Biochem] 2021 Sep; Vol. 58 (5), pp. 481-486. Date of Electronic Publication: 2021 Jun 02.

Zobrazit plný text záznamu

Akademický článek

Resistance mechanisms to osimertinib in EGFR-mutated advanced non-small-cell lung cancer: A multicentric retrospective French study.

Autor: Mehlman C; Department of Respiratory Diseases and Thoracic Oncology, APHP - Hopital Ambroise Pare, EA 4340 BECCOH, UVSQ, Paris Saclay University, Boulogne-Billancourt, France., Cadranel J; Chest Department-Thoracic Oncology Expert Center, AP-HP, Groupe Hospitalier HUEP, Hopital Tenon, Paris, France, and Sorbonne University, Paris, France., Rousseau-Bussac G; Chest Departement, Creteil Intercommunal Hospital, Créteil, France., Lacave R; Department of Solide Tumours Genetic, AP-HP, Groupe Hospitalier HUEP, Tenon Hospital, Paris, France, and Sorbonne University, Paris, France., Pujals A; Department of Pathology, Henri Mondor Hospital, AP-HP, Créteil, France., Girard N; Thorax Institute, Institute Curie and PSL University, Paris, France., Callens C; Department of Genetics, Institut Curie, Paris, France., Gounant V; Thoracic Oncology Department, University Hospital Bichat-Claude Bernard, AP-HP, Paris, France., Théou-Anton N; Genetics Department, University Hospital Bichat-Claude Bernard, AP-HP, Paris, France., Friard S; Pneumology Department, Foch Hospital, Suresnes, France., Trédaniel J; Pneumology Department, Saint-Joseph Hospital, Paris, France., Blons H; Molecular Biology Department, Georges Pompidou European Hospital, AP- HP, Paris, France and INSERM UMR-S1147, CNRS SNC 5014, Saints-Pères Research Center, Paris-Descartes University, Sorbonne Paris Cité University, Paris, France., Dujon C; Pneumology Department, André Mignot Hospital, Le Chesnay, France., Duchemann B; Oncology Department, Avicenne Hospital, AP-HP, Bobigny, France and Paris XIII University, Sorbonne Paris Cité, Paris, France and Laboratory of Immunomonitoring in Oncology, UMS 3655 CNRS/US 23 INSERM, Gustave Roussy Cancer Campus, Villejuif, France., Schischmanoff PO; Department of Molecular Oncogenetics, Avicenne Hospital, AP-HP, Bobigny, France and INSERM UMR U978/Paris XIII University, Sorbonne Paris Cité University, Paris, France., Chinet T; Department of Respiratory Diseases and Thoracic Oncology, APHP - Hopital Ambroise Pare, EA 4340 BECCOH, UVSQ, Paris Saclay University, Boulogne-Billancourt, France., Giroux Leprieur E; Department of Respiratory Diseases and Thoracic Oncology, APHP - Hopital Ambroise Pare, EA 4340 BECCOH, UVSQ, Paris Saclay University, Boulogne-Billancourt, France. Electronic address: etienne.giroux-leprieur@aphp.fr.

Publikováno v: Lung cancer (Amsterdam, Netherlands) [Lung Cancer] 2019 Nov; Vol. 137, pp. 149-156. Date of Electronic Publication: 2019 Sep 28.

Zobrazit plný text záznamu

Akademický článek

A STAT3-decoy oligonucleotide induces cell death in a human colorectal carcinoma cell line by blocking nuclear transfer of STAT3 and STAT3-bound NF-κB.

Autor: Souissi I; INSERM, Unité 978, Bobigny, France., Najjar I, Ah-Koon L, Schischmanoff PO, Lesage D, Le Coquil S, Roger C, Dusanter-Fourt I, Varin-Blank N, Cao A, Metelev V, Baran-Marszak F, Fagard R

Publikováno v: BMC cell biology [BMC Cell Biol] 2011 Apr 12; Vol. 12, pp. 14. Date of Electronic Publication: 2011 Apr 12.

Zobrazit plný text záznamu

Akademický článek

Prognostic impact of microsatellite instability in colorectal cancer patients treated with adjuvant FOLFOX.

Autor: Des Guetz G; Department of Oncology, Avicenne Hospital, Bodigny, France. Gaetan.des-guetz@wanadoo.fr, Lecaille C, Mariani P, Bennamoun M, Uzzan B, Nicolas P, Boisseau A, Sastre X, Cucherousset J, Lagorce C, Schischmanoff PO, Morere JF

Publikováno v: Anticancer research [Anticancer Res] 2010 Oct; Vol. 30 (10), pp. 4297-301.

Zobrazit plný text záznamu

Akademický článek

STAT1-dependent IgG cell-surface expression in a human B cell line derived from a STAT1-deficient patient.

Autor: Najjar I; INSERM, unité 978/Université Paris 13, UFR SMBH 74 rue Marcel Cachin, 93017 Bobigny cedex France., Deglesne PA, Schischmanoff PO, Fabre EE, Boisson-Dupuis S, Nimmerjahn F, Bornkamm GW, Dusanter-Fourt I, Fagard R

Publikováno v: Journal of leukocyte biology [J Leukoc Biol] 2010 Jun; Vol. 87 (6), pp. 1145-52. Date of Electronic Publication: 2010 Mar 03.

Zobrazit plný text záznamu

Vyhledávací nástroje:

Upřesnit hledání